Press Releases from Sempulse (3 total)
Sempulse® announces U.S. FDA 510(k) Clearance and the Commercial Launch of the …
San Marcos, TX, May 16, 2024 - Sempulse today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the commercial launch of the Sempulse Halo Vital Signs Monitoring System. The miniature wearable device is a durable, non-invasive, remote vital signs monitoring system that captures 5 major vital signs (SpO2, pulse rate, respiratory rate, core body temperature, and skin temperature) for general monitoring, Remote Patient Monitoring (RPM), telemedicine, and chronic…
Wearables in the battlefield: Sempulse saves lives with smarter triage.
San Diego, June 22, 2018 – In a move sure to make military veterans and the medical community take notice, Sempulse is improving battlefield survivability via a non-invasive vital signs sensor and a patented triage algorithm.
Their Halo monitor is only the size of a quarter and applies in seconds to the most reliable vital signs acquisition site on the body: behind the ear. Within two seconds it relays key vitals…
Sempulse: out of stealth mode with a bang – Wearables in the battlefield savin …
Wins finalist honors at SXSW and opens its fundraising
San Diego, June 15, 2018 – A new medical device company is improving battlefield triage. While the medical markets are generating lots of noise, Sempulse sensor technology is solving for the signal-to-noise ratio in field triage with a durable, non-invasive vital signs sensor and patented software platform.
Combat scenes are highly stressful, chaotic situations and the Sempulse Halo device delivers…
Go To Page: 1
